Business
Aurobindo arm Lannett’s facility in U.S.gets 4 U.S. FDA observations
Lannett’s Seymour manufacturing facility has the capacity to scale production to approximately 4 billion doses annually.
Read full story on The Hindu →
India — The Hindu
Business
Lannett’s Seymour manufacturing facility has the capacity to scale production to approximately 4 billion doses annually.
Read full story on The Hindu →
India — The Hindu
Lannett’s Seymour manufacturing facility has the capacity to scale production to approximately 4 billion doses annually.
This report is published with credit to The Hindu. The wire sent a summary; open the original for any extra context. Read on The Hindu →
Source: The Hindu. Published 25 Aug 2026, 11:22 am.
Most relevant

Critics said the children’s costume evoked blackface imagery. The retailer said, “We know we got this wrong, and we are deeply sorry.”
Read on The New York Times →Editor’s choice

The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
Read on The Hindu →